Group One Trading, L.P. Clear Point Neuro, Inc. Transaction History

Group One Trading, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$4.46 - $7.07 $26,300 - $41,691	5,897 Added 555.27%	6,959 $47,000
Q3 2023 Nov 09, 2023	BUY	$5.01 - $7.09 $5,320 - $7,529	1,062 New	1,062 $5,000
Q2 2022 Aug 11, 2022	SELL	$7.09 - $13.65 $21,815 - $42,001	-3,077 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$7.8 - $11.6 $63,788 - $94,864	-8,178 Reduced 72.66%	3,077 $32,000
Q4 2021 Feb 11, 2022	BUY	$11.08 - $18.86 $1,462 - $2,489	132 Added 1.19%	11,255 $126,000
Q3 2021 Nov 12, 2021	SELL	$16.58 - $22.25 $41,698 - $55,958	-2,515 Reduced 18.44%	11,123 $197,000
Q2 2021 Aug 10, 2021	BUY	$17.23 - $22.77 $234,138 - $309,421	13,589 Added 27732.65%	13,638 $260,000
Q1 2021 May 12, 2021	BUY	$15.19 - $29.0 $744 - $1,421	49 New	49 $1,000

6.81M

84.3K

56.7K

Ticker CLPT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,488,300
Market Cap $400M
Description
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.